Amgicin 200 Injection vial of 1 Injection

Gemciglan 200mg Injection is used in the treatment of non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer and ovarian cancer.

Gemcitabine 200mg

Amgicin 200 Injection may cause excessive drowsiness with alcohol

Amgicin 200 Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Gemcitabine : Nausea, Vomiting, Loss of appetite, Hair loss, Low blood platelets, Allergic reaction, Breathlessness, Decreased white blood cell count, Increased liver enzymes, Anemia (low number of red blood cells), Influenza like symptoms, Blood in urine, Skin rash, Protein in urine

No interaction found/established

Gemciglan 200mg Injection interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.

Q. Is Gemciglan a vesicant/ anthracycline/ prodrug?
Gemciglan is not a vesicant/ anthracycline/ prodrug

Q. Does Gemciglan cause hair loss or abdominal pain?
Yes, Gemciglan has hair loss and abdominal pain as side effects. Please consult your doctor immediately if you experience such side effects

Q. Is Gemciglan a cytotoxic or chemotherapy agent?
Yes, Gemciglan is a cytotoxic chemotherapy agent

Q. Does Gemciglan work in pancreatic cancer?
Yes, Gemciglan is used to treat pancreatic cancer.

Amgicin 200 Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.